The voice of the patient is increasing in every country and every region of the world. Patient groups - which vary in size and scope, sophistication and capabilities - represent these patients and often form around specific diseases.

Our commitment to find new and better ways to deliver the highest quality healthcare and the best medications has led to an enduring and trusted partnership between Novartis and the many groups representing patient interests.

Patient groups serve many purposes, advocating for the rights of patients, lobbying for better access and appropriate reimbursement for innovative medicines, raising awareness about diseases and their treatments, and helping patients navigate sometimes complex rules to get the best possible care. Novartis shares these goals.

These groups often need support, advice, tools, information and empowerment and Novartis seeks to provide those. For our company, patient groups can serve as allies to ensure open access to medicines, advise us about patient needs and concerns, and even guide us to new areas of research that patients believe are needed. In our dealings with these groups, we fully appreciate the importance of transparency, publicly disclosing any support offered and providing fair and balanced information about treatments from Novartis and other companies.

Read our position on patient group interaction and support
(73 KB)